Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose

Klin Wochenschr. 1986 Dec 15;64(24):1281-90. doi: 10.1007/BF01785710.

Abstract

A 55 years old patient suffering from exercise-induced muscle pain and stiffness due to primary myoadenylate deaminase deficiency has been successfully treated with D-ribose since 1984: single doses of 4 grams administered at the beginning of exercise prevented the symptoms completely; on continuation of exercise this dose had to be repeated all 10-30 min. Total doses of 50-60 g per day were tolerated without side-effects.

Publication types

  • Case Reports

MeSH terms

  • AMP Deaminase / deficiency*
  • Ammonia / blood
  • Drug Therapy, Combination
  • Humans
  • Hypoxanthine
  • Hypoxanthines / blood
  • Inosine / blood
  • Lactates / blood
  • Lactic Acid
  • Male
  • Middle Aged
  • Muscles / enzymology*
  • Neuromuscular Diseases / drug therapy*
  • Neuromuscular Diseases / enzymology
  • Nucleotide Deaminases / deficiency*
  • Physical Exertion
  • Ribose / therapeutic use*
  • Xylitol / therapeutic use

Substances

  • Hypoxanthines
  • Lactates
  • Hypoxanthine
  • Lactic Acid
  • Inosine
  • Ribose
  • Ammonia
  • Nucleotide Deaminases
  • AMP Deaminase
  • Xylitol